Deals
S&C, Skadden, Kirkland Advise on Allergan Deal: Business of Law
This article is for subscribers only.
Four U.S. law firms and two from Canada advised on Valeant Pharmaceuticals International Inc.’s deal to buy Allergan Inc., maker of the blockbuster Botox wrinkle treatment.
Sullivan & Cromwell LLP, Skadden, Arps, Slate, Meagher & Flom LLP and Toronto’s Osler, Hoskin & Harcourt LLP represented Valeant, while Kirkland & Ellis LLP and Canada’s Davies Ward Phillips & Vineberg LLP represented William Ackman’s Pershing Square Capital Management LP, which partnered with Valeant on the deal. Latham & Watkins LLP advised Allergan.